PAI-1 was shown to stimulate angiogenesis and facilitate tumor growth and metastasis in primary neuroblastoma tumors (65) and in ovarian cancer, its increased expression was correlated with tumor cell proliferation and overall poor prognosis. Here, SERPINE1 is linked to ovarian carcinoma.